Those with HIV were more likely to be colonized with community-associated methicillin-resistant Staphylococcus aureus than HIV-negative patients, and they were more likely to carry USA300 strains, researchers reported in Clinical Infectious Diseases.
“This study extends prior studies documenting the significant impact CA-MRSA has had on HIV-infected patients,” Kyle Popovich, MD, of Rush University Medical Center in Chicago, told Infectious Disease News. “There has been a sense that CA-MRSA rates have been decreasing in recent years. However, our results show a high burden of CA-MRSA in HIV-infected patients and move us beyond qualitative data to a quantitative understanding of this burden.”
Full Story »
Personalize your page!
Register for Healio to get content tailored to your specialty and areas of interest.
It’s FREE and only takes one minute.